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Abstract Protocols for the extraction of nuclear
proteins have been developed for cultured cells and
fresh tissue, but sometimes only frozen tissue is
available. We have optimized the homogenization
procedure and subsequent fractionation protocol for
the preparation of nuclear protein extracts from frozen
porcine left ventricular (LV) tissue. This method gave
a highly reproducible protein yield (6.5±0.7% of total
protein; mean±SE, n=9) and a 6-fold enrichment of
the nuclear marker protein B23. The nuclear protein
extracts were essentially devoid of cytosolic, myofil-
ament, and histone proteins. Compared to nuclear
extracts from fresh LV tissue, some loss of nuclear
proteins to the cytosolic fraction was observed. Using
this method, we studied the distribution of tyrosine-
phosphorylated signal transducer and activator of
transcription 3 (PY-STAT3) in LV tissue of animals
treated with the β-agonist dobutamine. Upon treat-
ment, PY-STAT3 increased 30.2±8.5-fold in total
homogenates, but only 6.9±2.1-fold (n=4, P=0.03)
in nuclear protein extracts. Of all PY-STAT3 formed,
only a minor fraction appeared in the nuclear fraction.
This simple and reproducible protocol yielded nuclear
protein extracts that were highly enriched in nuclear
proteins with almost complete removal of cytosolic
and myofilament proteins. This nuclear protein
extraction protocol is therefore well-suited for nuclear
proteome analysis of frozen heart tissue collected in
biobanks.
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Introduction
Preparation of nuclear protein extracts from tissue or
cultured cells is an important tool for the study of gene
regulation and the transcription factors (TFs) involved.
Nuclear protein extracts are widely employed to study
DNA binding of TFs in electrophoretic mobility shift
assays or to study trafficking of TFs between the cytosol
and the nucleus. Nuclear protein extracts are also well-
suited for nuclear proteome analysis as subcellular
fractionation greatly reduces the complexity of the
protein mixture, thus allowing detection of the low
abundant TFs [1, 2, 12]. Preparation of nuclear protein
extracts from fresh tissue samples or cultured cells is
relatively straightforward. However, it is often desirable
to utilize frozen tissue collected over a period of time as
for example in biobanks.
In light of these considerations, we set out to develop a
method for nuclear protein extraction from frozen cardiac
muscle tissue, which is notoriously difficult to homoge-
nize, and we compared this with standardized nuclear
protein extraction from fresh heart tissue. Nuclear protein
extracts from frozen heart tissue have already been
applied for gel shift assays [4, 7, 25, 32] and for the
determination of nuclear translocation of TFs [5, 6, 10,
11, 16, 17, 20, 29, 30]. However, homogenization and
fractionation protocols used in these studies vary widely.
Most of these studies did not report the yield of nuclear
proteins or the degree of contamination from other
subcellular compartments. Recently, a study was pub-
lished which analyzed the nuclear extraction from
frozen heart tissue with a commercial fractionation kit
[22]. The authors found poor purification and high
levels of contamination from other subcellular fractions.
In the present study, we developed a simple and
reproducible nuclear protein extraction method from
frozen left ventricular tissue by systematically optimiz-
ing the homogenization and fractionation steps. We
used cardiac tissue collected over time from pigs, a
large laboratory animal, of which the cardiac physiology
and anatomy closely resembles that of humans.
Material and methods
Experimental animals
Studies were performed in accordance with the Guide
for the Care and Use of Laboratory Animals (NIH
Publication No. 85-23, revised 1996) and with approv-
al of the Erasmus Medical Center Animal Care
Committee. Cardiac tissue was collected from a total
of 18 Yorkshire × Landrace swine. Animals were
sedated by an intramuscular injection of a mixture of
ketamine and midazolam, anesthetized with intrave-
nous pentobarbital (bolus + continuous infusion),
intubated, and ventilated [24, 26]. The thorax and
pericardium were opened and the heart was exposed.
In a subset of four pigs, dobutamine was infused in
consecutive doses of 2.5 and 10 μg/kg/min, for 10 min
each, followed by a 10-min wash out period. Heart rate
and LV contractility were determined as previously
described [24, 26]. Then the heart was arrested by
application of an electroshock from a 9-V battery [15]
and immediately excised. The left ventricle was
divided into subendocardial and subepicardial tissue
from the anterior, lateral, posterior, and septal area of
the left ventricle wall. Subsequently, cardiac tissue was
snap-frozen in liquid nitrogen (i.e., within 5 min of
excising the heart) and stored at −80°C.
Nuclear protein extraction from frozen tissue
Frozen heart tissue from nine pigs collected over a
period of 10 years was used for nuclear protein
extraction. Approximately 100 mg of frozen left
ventricular subendocardial tissue from the anterior
region was pulverized using a Mikro-Dismembrator U
(1,700 rpm, 4 min; Sartorius, Nieuwegein, The Nether-
lands), and the powder was immediately suspended in
4 ml ice-cold Dulbecco’s phosphate-buffered saline
(DPBS) (Lonza, Verviers, Belgium) containing protease
and phosphatase inhibitors (Complete, Roche Diagnos-
tics, Almere, The Netherlands, and phosphatase inhib-
itor cocktail 1 & 2, Sigma, St. Louis, IL, USA,
respectively). All further steps were carried out at 4°C.
After homogenization with a handheld glass-glass
Dounce Tissue grinder (5 times loose, 5 times tight
pestle; GPELtd, Leighton Buzzard, UK), the suspension
was centrifuged at 1,850×g for 15 min. The supernatant
was taken as the cytosolic fraction. The pellet was
resuspended in 10 volumes of hypotonic CER I buffer
(NE-PER kit, Thermo Scientific, Rockford, IL, USA)
containing protease (Protease Inhibitor Mix, Amersham
Biosciences, Piscataway, NJ, USA) and phosphatase
inhibitors and incubated for 10 min. Then, 55 μl of
detergent-containing CER II solution was added per
100 μl of the original pellet volume. This mixture was
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incubated for 1 min, followed by centrifugation at
14,000×g for 5 min, and the supernatant representing
the organelle fraction was collected. The pellet was
resuspended in 5 volumes of high-salt NER buffer
containing protease and phosphatase inhibitors, and
then incubated for 40 min and vortexed every 10 min.
Thereafter, the suspension was centrifuged at 14,000×g
for 10 min, and the supernatant was saved as the
nuclear protein extract. The final pellet containing
myofilament and histone proteins was resuspended in
500 μl DPBS with protease and phosphatase inhibitors.
All fractions were snap-frozen in liquid nitrogen and
stored at −80°C until further analysis.
Nuclear protein extraction from fresh LV tissue
Fresh heart tissue from five pigs was used. Nuclear
protein extraction protocol was performed with the
NE-PER kit (Thermo Scientific) according to the
manufacturer’s instructions. In short, the heart was
excised and a piece of left ventricular subendocardial
tissue from the anterior region was taken and rinsed
with ice-cold PBS to remove blood. The tissue was
cut into small pieces with a razor blade and placed in
1 ml hypotonic CER I buffer containing protease and
phosphatase inhibitors. All further steps were carried out
at 4°C. The tissue was homogenized by Teflon-glass
Potter homogenization. The suspension was incubated
on ice for 10 min. Then, 55 μl of detergent-containing
CER II solution was added per 1 ml of CER I buffer.
This mixture was incubated for 1 min, followed by
centrifugation at 14,000×g for 5 min, and the superna-
tant representing the cytosolic fraction was collected.
The pellet was resuspended in 500 μl NER buffer per
1 ml CER I, containing protease and phosphatase
inhibitors, and then incubated for 40 min and vortexed
every 10 min. Thereafter, the suspension was centri-
fuged at 14,000×g for 10 min, and the supernatant was
saved as the nuclear protein extract. The final pellet
containing the myofilament and histone protein was
resuspended in 500 μl DPBS with protease and
phosphatase inhibitors. All fractions were snap-frozen
in liquid nitrogen and stored at −80°C until further
analysis.
Immunohistochemistry
Cryocoupes (5 μm) were cut from left ventricular
tissue samples embedded in TissueTek. Sections were
probed with B23 antibody (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA) at 1:4,000 dilution,
followed by an anti-mouse IgG horseradish peroxi-
dase (HRP)-conjugated secondary antibody (DAKO,
Carpinteria, CA, USA) at 1:100 dilution. Peroxidase-
labeled immune complexes were visualized by incu-
bation with 3,3′-diaminobenzidine tetrahydrochloride
(DAKO) and the sections were counterstained with
hematoxylin.
Immunoblotting
The protein fractions were prepared in Laemmli’s
loading buffer [14], and protein concentration was
determined using the Bio-Rad RC DC protein assay
kit (Bio-Rad, Hercules, CA, USA) using bovine
serum albumin as standard. Equal quantities of
protein were loaded onto 12% sodium dodecyl sulfate
(SDS)-polyacrylamide gels. After electrophoresis,
proteins were transferred overnight to Immun-Blot
(for ECL, Bio-Rad) or Immobilon-FL (for Odyssey,
Millipore, Bedford, MA, USA) polyvinylidene
difluoride membranes. Protein transfer onto the blot
was checked with Ponceau S staining.
For enhanced chemiluminescence (ECL), blots were
blocked for 30 min with 0.5% milk powder (Campina
Melkunie BV, Eindhoven, The Netherlands) in Tris-
buffered saline (TBS)/0.1% Tween-20. Then, primary
antibodies were added to the block buffer at the dilutions
described in Table 1, and the blots were incubated for
90 min at room temperature or overnight at 4°C in the
case of tyrosine-phosphorylated signal transducer and
activator of transcription 3 (PY-STAT3). After washing
extensively with TBS/0.1% Tween-20, the blots were
incubated with the indicated amount (Table 1) of HRP-
conjugated secondary antibodies in block buffer for 1 h
or for 3 h in the case of PY-STAT3. After washing the
blots, ECL signals were generated with the Supersignal
West Femto Maximum Sensitivity Kit (Thermo Scien-
tific) on Hyperfilm ECL (Amersham).
For quantification, the Odyssey system using
fluorescently labeled secondary antibodies was ap-
plied as this technique is linear over a larger dynamic
range than ECL [19]. Blots were blocked for 1 h with
Odyssey blocking buffer (Li-Cor, Bad Homburg,
Germany) diluted 1:1 with DPBS. Blots were incu-
bated for 1 h with the primary antibodies (Table 1) in
block buffer containing 0.1% Tween-20. After exten-
sive washing in DPBS/0.1% Tween-20, the blots were
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incubated with IRDye800CW-coupled secondary
antibodies (Table 1) for 1 h in block buffer containing
0.1% Tween-20 and 0.01% SDS. Finally, images were
generated by scanning the blots on the Odyssey
Infrared Imaging System (Li-Cor).
Statistical analysis
Results are expressed as mean±SE. Unpaired Student’s
t test was used to compare means. Results were
considered statistically significant atP<0.05 (two-tailed).
Results
Nuclear protein extraction procedure
To follow the nuclear proteins during homogenization
and fractionation and to determine the recovery of
nuclear proteins in the nuclear protein extract, we
used the abundant nuclear protein nucleophosmin
(B23) as a nuclear marker protein [9, 27]. By
immunohistochemistry on frozen cardiac tissue, we
showed that localization of B23 is almost completely
restricted to the nuclei (Fig. 1).
Homogenization of the frozen LV tissue was found
to be a critical step in the nuclear protein extraction
protocol. Following Polytron homogenization as
described by Lin et al. [17] and Gurusamy et al.
[11], most of the B23 protein appeared in the
cytosolic fraction (data not shown). This was pre-
vented by more gentle homogenization of heart tissue
cut into small pieces, using a handheld glass-glass
Dounce homogenizer. However, this method resulted
in a large intra-assay variation in the amount of total
nuclear protein (7.1±1.6%, range 2.6–14.6%; n=8)
and the amount of B23 recovered in the nuclear
fraction as determined by immunoblotting (6.6±1.9
arbitrary units, range 2.9–19.3; n=8). The reproduc-
ibility of total protein and B23 recovery in the nuclear
protein fraction was markedly improved upon intro-
duction of a tissue pulverization step at liquid
nitrogen temperature before Dounce homogenization
in PBS (see below).
Next, we tested several fractionation protocols based
on differential centrifugation at different sucrose densi-
ties [8, 13]. In our hands, these laborious protocols
gave variable degrees of B23 and total protein
recovery in the nuclear fraction (data not shown).
Instead, we tested whether the commercial nuclear
protein extraction kit from Thermo Scientific, which
was specifically designed to isolate nuclear and
cytoplasmic proteins from fresh tissue, could be made
suitable for frozen tissue. After pulverization and
homogenization in PBS, we introduced an additional
centrifugation step, which leaves the contents of the
nuclei damaged by freeze-thawing in the soluble
fraction together with the cytosolic proteins (further
denoted as the cytosolic fraction). The pellet containing
the nuclei was then resuspended in a small volume of
CER I buffer, and the extraction procedure was
continued according to the manufacturer’s instructions.
The fractionation protocol is based on swelling of the
cells and organelles in hypotonic buffer, followed by
Table 1 Antibodies and dilutions used for immunoblotting and visualization by ECL and Odyssey
Antibody ECL Odyssey
Antigen Speciesa Supplier Primary Secondaryb Primary Secondaryb
GAPDH M Chemicon Int 1:3,200,000 1:8,000 1:200,000 1:2,000
SERCA2 R Santa Cruz 1:20,000 1:8,000 1:2,000 1:2,000
Prohibitin R Abcam 1:8,000 1:8,000 1:2,000 1:2,000
α-Actin M Sigma 1:2,000 1:2,000 1:1,000 1:2,000
Histone H3 R Eurogentec 1:200,000 1:8,000 1:100,000 1:2,000
B23 M Santa Cruz 1:100,000 1:8,000 1:8,000 1:2,000
PY-STAT3 M Cell Signaling 1:500 1:2,000 – –
aMouse (M), rabbit (R) antibodies
b Secondary antibodies for ECL were HRP-conjugated goat anti-mouse or anti-rabbit IgG from Thermo Scientific, and for Odyssey,
the secondary antibodies were IRDye800CW-conjugated goat anti-mouse or anti-rabbit IgG from Li-Cor
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bursting of the swollen cells and organelles by deter-
gent. The nucleus is spared from this hypotonic swelling
as its nuclear pores allow for the free diffusion of water
and electrolytes in and out of the nucleus. The nuclear
proteins were extracted from the nucleus by incubation
in high-salt buffer. This homogenization and fraction-
ation protocol is relatively simple and showed the
highest reproducibility of all the methods tested. A
schematic overview of the overall nuclear protein
extraction procedure on frozen LV tissue is depicted in
Fig. 2a and compared with a standard nuclear protein
extraction protocol on fresh cardiac tissue (Fig. 2b).
The final pellet fraction left after incubation with
nuclear extraction reagent principally contains myofil-
ament proteins and also histone proteins as the salt
concentration is too low to enable their extraction from
the DNA [28].
Nuclear protein enrichment and contamination
Nuclear fractions were obtained that contained 6.5±0.7%
(range 3.9–8.6%, n=9) of the total protein (Fig. 2a) with
more than 6-fold enrichment of B23 (Table 2). B23
enrichment was similar in nuclear protein extracts from
frozen and fresh tissues (Table 2). However, compared
to the extraction procedure on fresh cardiac tissue, the
total protein yield in the nuclear fraction was signifi-
cantly lower (P<0.001, Fig. 2). In extracts from frozen
tissue, more B23 was present in the cytosolic fraction
than with fresh tissue, probably due to damage of some
nuclei during freezing and thawing (Fig. 3). As
expected from the relative content of cytosolic and
myofilamental proteins in heart tissue, most of the total
cellular protein was recovered in the cytosolic and final
pellet fractions independent of whether frozen or fresh
tissue was used. The relative recovery in these fractions
differed between frozen and fresh tissues. It should be
noted, however, that due to freeze-thawing, the cytosolic
fraction is likely to be contaminated with some proteins
derived not only from nuclei but also from damaged
organelles. With fresh tissue and using the NE-PER kit,
organelle marker proteins ended up in the cytosolic
fraction as expected. Total protein recovery in all
fractions combined was similar for frozen and fresh
tissue extracts (78.5±2.7% vs. 80.6±6.3%).
To determine the contamination of the nuclear
protein extracts from frozen tissue with proteins from
other subcellular compartments, we tested each fraction
for the presence of different subcellular marker proteins
(Fig. 4). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) ended up almost exclusively in the cytosolic
fraction, with no detectable contamination of the
nuclear protein extract. The SR and mitochondria
Fig. 1 Subcellular localization of B23 in cardiac tissue.
Cryocoupes of cardiac tissue were immunostained (brown)
without (a) or with anti-B23 antibody (b, c) and counterstained
with hematoxylin (blue). Bar represents 50 μm (a, b) or
10 μm (c)
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markers SERCA2 and prohibitin were 8- and 6-fold
enriched in the organelle fraction. Nevertheless, some
SERCA2 and prohibitin were detected in the nuclear
fraction, but these represented only a small percentage
(Table 2). Similar results were obtained using ATP
synthase subunit β as marker for mitochondrial marker
(data not shown). The myofilament marker α-actin was
recovered almost exclusively in the final pellet fraction,
with only a minor contamination in the nuclear protein
extract. The nucleosomemarker histone H3 fractionated
almost exclusively to the final pellet fraction, which is
expected as higher salt concentrations are needed to
extract histones from the DNA [28].
Nuclear appearance of PY-STAT3
We employed our method to address the question
whether phosphorylation of the TF STAT3 to PY-
STAT3 leads to its nuclear accumulation, where it
may affect gene expression. In recent years, evidence
has emerged that phosphorylation of STAT3 does not
necessarily lead to nuclear translocation [21, 23]. It is
therefore necessary to demonstrate the nuclear accu-
mulation of PY-STAT3 when studying PY-STAT3-
dependent gene expression. Stimulation of heart
tissue with β-adrenergic agonists leads to STAT3
phosphorylation [18, 31] and increased transcriptional
activity [31]. Intravenous infusion with the β-
adrenergic agonist dobutamine in swine resulted in a
significant increase in heart rate (from 121±10 before
Fig. 2 Nuclear protein extraction protocols from frozen and fresh
cardiac tissues. Protocols for the extraction of nuclear protein from
frozen (a) and fresh (b) LV tissues are schematically depicted.
The amount of protein in each fraction is expressed as a
percentage of total protein in the homogenate. Data are mean±SE
for nine (frozen) and five (fresh) extractions performed on
independent LV tissue samples
Table 2 Quantification of marker proteins in their specific
marker compartment and in the nuclear protein extract
Marker compartment Nuclear extract
Compartment RE RE
Frozen tissue
GAPDH Cytosol 2.5±0.3 0.0±0.0
SERCA2 Organelles 8.0±1.6 0.9±0.3
Prohibitin Organelles 5.8±0.8 0.7±0.2
α-Actin Final pellet 3.0±0.1 0.1±0.1
Histone H3 Final pellet 4.7±0.4 0.2±0.1
B23 Nuclei 6.2±1.7 6.2±1.7
Fresh tissue
B23 Nuclei 7.6±1.6 7.6±1.6
Data are mean±SE from four independent experiments. Quan-
titative data were obtained with the Odyssey system
RE relative enrichment—the fold increase in protein abundance
relative to the total homogenate
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to 170±7 bpm during dobutamine infusion, n=4) and
LV contractility (LV dP/dtmax from 1,778±223 before
to 4,955±1,052 mmHg/s during dobutamine infusion,
n=4). From the treated and control sham-operated
animals, total homogenates and nuclear protein
extracts were prepared from frozen LV tissue samples.
Tyrosine-phosphorylated STAT3 was 30.2±8.5-fold
higher (n=4, P=0.01) in the total homogenates from
dobutamine-treated animals compared to controls
(Fig. 5a). In nuclear protein extracts, PY-STAT3 was
6.9±2.1-fold higher (n=4; P=0.03) in animals treated
with dobutamine than in controls (Fig. 5b). In Fig. 5c,
the distribution of PY-STAT3 in the different fractions
is shown. PY-STAT3 was detectable in all fractions,
but the majority of PY-STAT3 was present in the
cytosolic fraction. In contrast, the amount of B23 in
this fraction was relatively low, which indicates that
the presence of PY-STAT3 in this fraction is not
merely due to leakage from damaged nuclei.
Discussion
In this report, we describe an optimized nuclear
protein extraction protocol for frozen porcine heart
tissue. With this relatively simple protocol, we can
reproducibly obtain nuclear protein extracts with high
enrichment of nuclear proteins, which are essentially
devoid of cytosolic, myofilament, and histone pro-
teins. The protein yields of the nuclear fractions are
higher in extracts from fresh tissue, but this can be
explained by loss of proteins to the cytosolic fraction
from nuclei damaged during freeze-thawing as illus-
trated by increased appearance of B23 in the cytosolic
fraction (Fig. 3). We have used B23 as nuclear marker
protein. B23 has been reported to shuttle between the
cytoplasm and the nucleus in isolated chick or
interspecies (mouse-chick) heterokaryon fibroblast
cell lines [3]. If shuttling also occurs in porcine
cardiomyocytes, the cytosolic appearance of B23 may
not only be due to loss of nuclear proteins from
Fig. 5 Effect of dobutamine on PY-STAT3 distribution. PY-
STAT3 amount was determined in total homogenates (a) and in
nuclear protein extracts (b) from frozen LV tissue of four swine
treated without (control) or with dobutamine (+dobu). GAPDH
and B23 were used as loading control, respectively. c Nuclear
protein extraction was performed in parallel on two frozen LV
samples of swine treated with dobutamine. Of each fraction,
10 μg was analyzed by immunoblotting. Hom total homoge-
nate, Cyt cytosolic fraction, Org organellar fraction, Nuc
nuclear protein extract, Pel final pellet fraction
Fig. 4 Subcellular markers in subcellular fractions from frozen
LV tissue. Fractionation was performed in parallel on two
different frozen LV tissue samples. Of each fraction, 10 μg was
analyzed by immunoblotting. Hom total homogenate, Cyt
cytosolic fraction, Org organellar fraction, Nuc nuclear protein
extract, Pel final pellet fraction
Fig. 3 Distribution of B23 in the cytosolic and nuclear fractions
from fresh and frozen tissues. Fractionationwas performed on four
different frozen and fresh LV tissue samples. Of each fraction,
10 μg was analyzed by immunoblotting. Hom total homogenate,
Cyt cytosolic fraction, Nuc nuclear protein extract
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damaged nuclei, but also to active shuttling, thereby
leading to an underestimation of the enrichment of
nuclear proteins by our extraction procedure. We
show, however, that B23 was almost exclusively
localized in the nuclei of porcine LV tissue (Fig. 1).
Furthermore, in the nuclear extracts from fresh tissue,
where the nuclei are not damaged by freeze-thawing,
almost no B23 is seen in the cytosolic fraction
(Fig. 3).
When studying transcription factors, it is critical
that the cytosolic proteins are removed from the
nuclear protein extracts as a number of TFs are
present in their inactive form in the cytosol (e.g.,
NFAT). Using this protocol, the cytosolic marker
protein GAPDH was not observed in the nuclear
fraction. Since most of the abundant cytoplasmic
proteins, i.e., the cytosolic and myofilamental pro-
teins, as well as the most abundant nuclear proteins,
i.e., the histones, are removed, the resulting nuclear
protein extract appears to be aptly suited for further
analysis of TF abundance and function. We are
planning to apply this method to nuclear proteome
profiling on remodeled [26] and hibernating [24]
myocardium. Since there is minimal contamination of
the nuclear protein extract with cytosolic proteins, this
method is highly useful for the analysis of nuclear
presence of TFs in different conditions.
We tested the applicability of the method by studying
the distribution of PY-STAT3 in porcine myocardium
after β-adrenergic stimulation. This stimulation causes
phosphorylation of STAT3 and an increase in its
transcriptional activity [31]. However, only a small
part of the PY-STAT3 pool was found in nuclear
protein extracts from dobutamine-treated animals
(Fig. 5c), indicating that only a minority of PY-
STAT3 translocates to the nucleus. Also, the increase
in PY-STAT3 is much higher in the tissue homogenate
than in the nuclear protein extracts from dobutamine-
treated animals. This demonstrates the necessity to
perform nuclear protein extractions when studying the
role of PY-STAT3 in the regulation of gene expression.
In a recent study, Murray et al. [22] tested a nuclear
extraction protocol on frozen heart tissue and reported
nuclear extracts with major contamination from
cytosolic GAPDH and mitochondrial ATP synthase
subunit β marker proteins. One difference with our
study is the use of a different tissue homogenization
method, which we found to be a crucial step in
ensuring proper separation of the fractions. Murray et
al. also used a different nuclear extraction kit, using
DNAse to cut DNA and release all DNA bound
proteins. In contrast, the kit we used employs salt
extraction, which likely explains the absence of
histone proteins in the nuclear extract.
An inherent limitation of whole tissue homogeniza-
tion is that it does not allow delineation between nuclear
protein extracts from different cell types present in
cardiac tissue, including fibroblasts, vascular smooth
muscle cells, and endothelial cells in addition to
cardiomyocytes. Future studies using laser capture
approaches are needed to study nuclear extracts from
specific cell typeswithin the heart, but may yield too low
levels of transcription factors to be quantified reliably.
In conclusion, the preparation of nuclear protein
extracts from frozen tissue allows for the study of
nuclear localization of TFs and of TF function in gene
regulation, years after tissue has been collected. We
used tissue samples that had been stored for 1 week to
10 years and observed no effect of the time of storage
on the amount of nuclear protein recovered (data not
shown). In addition, using frozen tissue allows for the
preparation of nuclear protein extracts from several
LV biopsies in parallel, thereby reducing potential
day-to-day variability. This method will not only
enable the study of nuclear protein profiles of heart
tissue from experimental animals present in tissue
banks, but may also be applicable to the analysis of
human heart biopsies collected in biobanks.
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